Relevance of the MEK/ERK signaling pathway in the metabolism of activated macrophages: A metabolomic approach

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 1402-1410

  Través, Paqui G ^a   De Atauri, Pedro ^b   Marín, Silvia ^b   Pimentel Santillana, María ^a   Rodríguez Prados, Juan Carlos ^b   Marín De Mas, Igor ^b   Selivanov, Vitaly A ^b   Martín Sanz, Paloma ^a,c   Boscá, Lisardo ^a,c   Cascante, Marta ^b  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; FRUCTOSE 2,6 BISPHOSPHATE; GLUCOSE; GLUTAMINE; LACTIC ACID; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; PENTOSE PHOSPHATE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; BIOINFORMATICS; CELL STIMULATION; CITRIC ACID CYCLE; CONTROLLED STUDY; ENZYME INHIBITION; GLUCOSE TRANSPORT; GLYCOLYSIS; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; METABOLOMICS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CARBOHYDRATE METABOLISM; COMPUTATIONAL BIOLOGY; GLYCOLYSIS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; METABOLISM; METABOLOMICS; PENTOSE PHOSPHATE PATHWAY;

EID: 84856571459     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101781     Document Type: Article

References (43)

1. Gordon, S., and F. O. Martinez. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
2. Gordon, S. 2007. The macrophage: past, present and future. Eur. J. Immunol. 37 (Suppl. 1): S9-S17. (Pubitemid 350131264)
3. Nathan, C. 2002. Points of control in inflammation. Nature 420: 846-852. (Pubitemid 36019637)
4. Hu, X., S. D. Chakravarty, and L. B. Ivashkiv. 2008. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feed-forward and feedback inhibition mechanisms. Immunol. Rev. 226: 41-56.
5. Martinez, F. O., A. Sica, A. Mantovani, and M. Locati. 2008. Macrophage activation and polarization. Front. Biosci. 13: 453-461. (Pubitemid 351599757)
6. Pasare, C., and R. Medzhitov. 2004. Toll-like receptors: linking innate and adaptive immunity. Microbes Infect. 6: 1382-1387. (Pubitemid 41110581)
7. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686. (Pubitemid 39457982)
8. Nathan, C., and A. Ding. 2010. Nonresolving inflammation. Cell 140: 871-882.
9. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177: 7303-7311. (Pubitemid 44715100)
10. Rao, K. M. 2001. MAP kinase activation in macrophages. J. Leukoc. Biol. 69: 3-10. (Pubitemid 32095111)
11. Rao, K. M., T. Meighan, and L. Bowman. 2002. Role of mitogen-activated protein kinase activation in the production of inflammatory mediators: differences between primary rat alveolar macrophages and macrophage cell lines. J. Toxicol. Environ. Health A 65: 757-768. (Pubitemid 34553597)
12. Bain, J., L. Plater, M. Elliott, N. Shpiro, C. J. Hastie, H. McLauchlan, I. Klevernic, J. S. Arthur, D. R. Alessi, and P. Cohen. 2007. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408: 297-315.
13. Stebbins, J. L., S. K. De, T. Machleidt, B. Becattini, J. Vazquez, C. Kuntzen, L. H. Chen, J. F. Cellitti, M. Riel-Mehan, A. Emdadi, et al. 2008. Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc. Natl. Acad. Sci. USA 105: 16809-16813.
14. Rodríguez-Prados, J. C., P. G. Través, J. Cuenca, D. Rico, J. Aragonés, P. Martín-Sanz, M. Cascante, and L. Boscá. 2010. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J. Immunol. 185: 605-614.
15. Odegaard, J. I., R. R. Ricardo-Gonzalez, A. Red Eagle, D. Vats, C. R. Morel, M. H. Goforth, V. Subramanian, L. Mukundan, A. W. Ferrante, and A. Chawla. 2008. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 7: 496-507. (Pubitemid 351729205)
16. Wu, G. Y., C. J. Field, and E. B. Marliss. 1991. Glucose and glutamine metabolism in rat macrophages: enhanced glycolysis and unaltered glutaminolysis in spontaneously diabetic BB rats. Biochim. Biophys. Acta 1115: 166-173.
17. Rosa, L. F., Y. Cury, and R. Curi. 1992. Effects of insulin, glucocorticoids and thyroid hormones on the activities of key enzymes of glycolysis, glutaminolysis, the pentose-phosphate pathway and the Krebs cycle in rat macrophages. J. Endocrinol. 135: 213-219.
18. Zeyda, M., and T. M. Stulnig. 2007. Adipose tissue macrophages. Immunol. Lett. 112: 61-67. (Pubitemid 47379852)
19. Marin, S., W. N. Lee, S. Bassilian, S. Lim, L. G. Boros, J. J. Centelles, J. M. FernAndez-Novell, J. J. Guinovart, and M. Cascante. 2004. Dynamic profiling of the glucose metabolic network in fasted rat hepatocytes using [1,2-13C2]glucose. Biochem. J. 381: 287-294. (Pubitemid 38932235)
20. Ramos-Montoya, A., W. N. Lee, S. Bassilian, S. Lim, R. V. Trebukhina, M. V. Kazhyna, C. J. Ciudad, V. Noé, J. J. Centelles, and M. Cascante. 2006. Pentose phosphate cycle oxidative and nonoxidative balance: A new vulnerable target for overcoming drug resistance in cancer. Int. J. Cancer 119: 2733-2741. (Pubitemid 44846223)
21. Prieto, P., J. Cuenca, P. G. Través, M. Fernández-Velasco, P. Martín-Sanz, and L. Boscá. 2010. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways. Cell Death Differ. 17: 1179-1188.
22. Martin-Sanz, P., M. Cascales, and L. Boscá. 1989. Glucagon-induced changes in fructose 2,6-bisphosphate and 6-phosphofructo-2-kinase in cultured rat foetal hepatocytes. Biochem. J. 257: 795-799. (Pubitemid 19050136)
23. de Atauri, P., A. Benito, P. Vizán, M. Zanuy, R. Mangues, S. Marín, and M. Cascante. 2011. Carbon metabolism and the sign of control coefficients in metabolic adaptations underlying K-ras transformation. Biochim. Biophys. Acta 1807: 746-754.
24. Traves, P. G., S. Hortelano, M. Zeini, T. H. Chao, T. Lam, S. T. Neuteboom, E. A. Theodorakis, M. A. Palladino, A. Castrillo, and L. Bosca. 2007. Selective activation of liver X receptors by acanthoic acid-related diterpenes. Mol. Pharmacol. 71: 1545-1553. (Pubitemid 47010907)
25. Lee, W. N., L. O. Byerley, E. A. Bergner, and J. Edmond. 1991. Mass isotopomer analysis: theoretical and practical considerations. Biol.Mass Spectrom. 20: 451-458.
26. Schmidt, K., M. Carlsen, J. Nielsen, and J. Villadsen. 1997. Modeling isotopomer distributions in biochemical networks using isotopomer mapping matrices. Biotechnol. Bioeng. 55: 831-840. (Pubitemid 27360504)
27. Cascante, M., and S. Marin. 2008. Metabolomics and fluxomics approaches. Essays Biochem. 45: 67-81.
28. Sauer, U. 2006. Metabolic networks in motion: 13C-based flux analysis. Mol. Syst. Biol. 2: 62.
29. Wiechert, W., M. Möllney, S. Petersen, and A. A. de Graaf. 2001. A universal framework for 13C metabolic flux analysis. Metab. Eng. 3: 265-283. (Pubitemid 32748170)
30. Wiechert, W., M. Möllney, N. Isermann, M. Wurzel, and A. A. de Graaf. 1999. Bidirectional reaction steps in metabolic networks: III. Explicit solution and analysis of isotopomer labeling systems. Biotechnol. Bioeng. 66: 69-85. (Pubitemid 32262268)
31. Wiechert, W. 2007. The thermodynamic meaning of metabolic exchange fluxes. Biophys. J. 93: 2255-2264. (Pubitemid 47437608)
32. Feng, G. J., H. S. Goodridge, M. M. Harnett, X. Q. Wei, A. V. Nikolaev, A. P. Higson, and F. Y. Liew. 1999. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J. Immunol. 163: 6403-6412.
33. Bustos, R., and F. Sobrino. 1992. Stimulation of glycolysis as an activation signal in rat peritoneal macrophages. Effect of glucocorticoids on this process. Biochem. J. 282: 299-303.
34. Newsholme, P., S. Gordon, and E. A. Newsholme. 1987. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem. J. 242: 631-636. (Pubitemid 17049481)
35. Bando, H., T. Atsumi, T. Nishio, H. Niwa, S. Mishima, C. Shimizu, N. Yoshioka, R. Bucala, and T. Koike. 2005. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Clin. Cancer Res. 11: 5784-5792. (Pubitemid 41170304)
36. Calvo, M. N., R. Bartrons, E. Castaño, J. C. Perales, A. Navarro-Sabaté, and A. Manzano. 2006. PFKFB3 gene silencing decreases glycolysis, induces cellcycle delay and inhibits anchorage-independent growth in HeLa cells. FEBS Lett. 580: 3308-3314. (Pubitemid 44251000)
37. Bensaad, K., E. C. Cheung, and K. H. Vousden. 2009. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J. 28: 3015-3026.
38. Li, H., and G. Jogl. 2009. Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator). J. Biol. Chem. 284: 1748-1754.
39. Tomilov, A. A., V. Bicocca, R. A. Schoenfeld, M. Giorgio, E. Migliaccio, J. J. Ramsey, K. Hagopian, P. G. Pelicci, and G. A. Cortopassi. 2010. Decreased superoxide production in macrophages of long-lived p66Shc knock-out mice. J. Biol. Chem. 285: 1153-1165.
40. Fritz, J. M., L. D. Dwyer-Nield, and A. M. Malkinson. 2011. Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation. Mol. Cancer 10: 76.
41. Barbarroja, N., R. López-Pedrera, M. D. Mayas, E. García-Fuentes, L. Garrido-Sánchez, M. Macías- González, R. El Bekay, A. Vidal-Puig, and F. J. Tinahones. 2010. The obese healthy paradox: is inflammation the answer? Biochem. J. 430: 141-149.
42. Jager, J., T. Grémeaux, M. Cormont, Y. Le Marchand-Brustel, and J. F. Tanti. 2007. Interleukin-1beta-induced insulin resistance in adipocytes through downregulation of insulin receptor substrate-1 expression. Endocrinology 148: 241-251. (Pubitemid 46021456)
43. Kopp, A., C. Buechler, M. Bala, M. Neumeier, J. Schölmerich, and A. Schäffler. 2010. Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3. Endocrinology 151: 1097-1108.